Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Dena, Howard"'
Autor:
Talha Munir, Alexandra Pitchford, Adrian Bloor, Andrew Pettitt, Piers E.M. Patten, Francesco Forconi, Anna Schuh, Christopher P Fox, Simona Gatto, Ben Kennedy, John Gribben, Nicholas Pemberton, Oonagh Sheehy, Gavin Preston, Dena Howard, Anna Hockaday, David Cairns, Sharon Jackson, Natasha Greatorex, Nichola McWhirter, Jane Shingles, Kate Cwynarski, Shankara Paneesha, David Allsup, Andrew Rawstron, Peter Hillmen
Publikováno v:
Blood. 140:231-233
Autor:
Talha Munir, Jake Emmerson, Anna Hockaday, Jamie B. Oughton, Dena Howard, David Phillips, Jeff Neilson, Nicholas Pemberton, Shankara Paneesha, Ben Kennedy, Andy Rawstron, Peter Hillmen
Publikováno v:
British journal of haematologyREFERENCES. 199(5)
The GA101 (obinutuzumab) monocLonal Antibody as Consolidation Therapy In chronic lymphocytic leukaemia (CLL) (GALACTIC) was a seamless phase II/III trial designed to test whether consolidation with obinutuzumab is safe and eradicates minimal residual
Autor:
David John Allsup, Zoe Craig, David Cairns, Dena Howard, Anna Hockaday, Adrian Bloor, Zarni Soe, Christopher Pepper, Valter Gattei, Antonella Zucchetto, Pauline Robbe, Ruth Clifford, Anna Schuh, Talha Munir, Andrew Rawstron, Peter Hillmen
Publikováno v:
American Journal of Hematology. 97
Autor:
David John, Allsup, Zoe, Craig, David, Cairns, Dena, Howard, Anna, Hockaday, Adrian, Bloor, Zarni, Soe, Christopher, Pepper, Valter, Gattei, Antonella, Zucchetto, Pauline, Robbe, Ruth, Clifford, Anna, Schuh, Talha, Munir, Andrew, Rawstron, Peter, Hillmen
Publikováno v:
American journal of hematologyREFERENCES. 97(5)
Autor:
Moya Young, Alexandra Pitchford, David Allsup, Nicholas Pemberton, Gavin Preston, Jeffrey R. Neilson, Ben Kennedy, Shankara Paneesha, Gamal Sidra, Piers Em Patten, Adrian Bloor, Natasha Greatorex, Talha Munir, Francesco Forconi, Michelle Furtado, Simona Gatto, Anna Hockaday, Dena Howard, Renata Walewska, Peter Hillmen, Anna Schuh, Christopher P. Fox, Kate Cwynarski, Angus Broom, Sharon Jackson, David A Cairns, Nicholas J. Morley
Publikováno v:
Blood. 138:2636-2636
Introduction: Ibrutinib (Ibr) is the first approved irreversible BTK inhibitor. Cardiovascular (CV) adverse events, include hypertension (HT) and atrial fibrillation (AF). Ventricular tachyarrhythmias and sudden death have been reported possibly due
Autor:
Shankara Paneesha, Anna Hockaday, Piers Em Patten, Nagah Elmusharaf, David A Cairns, Ben Kennedy, Alexandra Pitchford, Peter Hillmen, Adrian Bloor, David Allsup, Sharon Jackson, Nicholas J. Morley, Kate Cwynarski, Gamal Sidra, Gavin Preston, Talha Munir, Francesco Forconi, Angus Broom, Dena Howard, Michelle Furtado, Anna Schuh, Natasha Greatorex, Renata Walewska, Christopher P. Fox, Moya Young, Nicholas Pemberton, Jeffrey R. Neilson
Publikováno v:
Blood. 138:642-642
Introduction: The most effective chemoimmunotherapy (CIT) in previously untreated CLL is the combination of fludarabine, cyclophosphamide and rituximab (FCR). Ibrutinib (I), the first irreversible inhibitor of Bruton's tyrosine kinase approved for CL